Pharmena S.A. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was PLN 0.01 million compared to PLN 0.154 million a year ago. Net income was PLN 0.235 million compared to net loss of PLN 0.155 million a year ago.

Basic earnings per share from continuing operations was PLN 0.02 compared to basic loss per share from continuing operations of PLN 0.11 a year ago. Diluted earnings per share from continuing operations was PLN 0.02 compared to diluted loss per share from continuing operations of PLN 0.11 a year ago. Basic earnings per share was PLN 0.02 compared to basic loss per share of PLN 0.01 a year ago.

Diluted earnings per share was PLN 0.02 compared to diluted loss per share of PLN 0.01 a year ago.